Skip to content

Clinical trials

Phase 3 Leukemia, Myeloid, Acute trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 3 Country / region: Denmark Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20151
20173
20191
20211
20222
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting5
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Astex Pharmaceuticals, Inc.2
Stichting Hemato-Oncologie voor Volwassenen Nederland2
Astellas Pharma Global Development, Inc.1
Fred Hutchinson Cancer Center1
Gilead Sciences1
Janssen Research & Development, LLC1
PedAL BCU, LLC1
University of Aarhus1
Vastra Gotaland Region1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute13
Leukemia, Lymphocytic, Chronic, B-Cell2
Multiple Myeloma2
Neoplasms2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Hematologic Neoplasms1
Hodgkin Disease1
Leukemia1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
Leukemia, Prolymphocytic1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.